Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeron Eaves

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|July 16, 2010
Ask your doctorJeffrey J Stewart, Jeron Eaves, Ben Bonifant
Chemistry & Biology|July 28, 2010
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90Patrick Fadden, Kenneth H Huang, James M Veal, et al.
Journal of Medicinal Chemistry|June 26, 2009
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agentsKenneth H Huang, James M Veal, R Patrick Fadden, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|July 16, 2010
Ask your doctorJeffrey J Stewart, Jeron Eaves, Ben Bonifant
Chemistry & Biology|July 28, 2010
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90Patrick Fadden, Kenneth H Huang, James M Veal, et al.
Journal of Medicinal Chemistry|June 26, 2009
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agentsKenneth H Huang, James M Veal, R Patrick Fadden, et al.
Pageof 1